Women in the third trimester of pregnancy who take supplements of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) reduce their children’s risk of persistent wheeze or asthma as well as of lower respiratory tract infections, a study in Denmark demonstrated.
A leading asthma inhaler will now be available to additional younger asthma patients, after FDA approved Spiriva Respimat (Boehringer Ingelheim) for the long-term, once-daily maintenance treatment of asthma in people age 6 and older.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in the American Journal of Respiratory and Critical Care Medicine that looked at whether asthma in childhood contributed to the development of childhood obesity.
A study looks at the effectiveness of a dendritic cell vaccine in early-stage HER2-positive breast cancer. Plus: A look at whether fish oil consumed during pregnancy reduces the risk of asthma in offspring.
Results of a randomized trial in children with asthma comparing concomitant use of the inhaled glucocorticoid fluticasone propionate plus the long-acting beta-agonist (LABA) salmeterol with use of fluticasone alone indicate that the answer to this question is “no.”
Young children with asthma who take acetaminophen to alleviate pain or fever are no more likely than those who take ibuprofen for this purpose to experience asthma complications, a randomized, double-blind trial showed.